Dr. Brian Grunau receives funding from the COVID-19 Immunity Task Force

We are proud to share that Dr. Brian Grunau has received $2.1 million of funding from Public Health Agency of Canada’s COVID-19 Immunity Task Force (CITF) funding opportunity, for his research project entitled COVID-19 Occupational Risks, Seroprevalence and Immunity among Paramedics in Canada (CORSIP Canada)!

The funding from CITF is part of an opportunity related to COVID-19 Hot Spots involving population-based studies that will report novel data relating to COVID-19 infection and immunity in three types of COVID-19 “hot spots”: i) geographic areas; ii) long-term care facilities; and iii) occupation groups.

Dr. Grunau’s study will contribute to our understanding of the dynamics of SARS-CoV-2 infection and immunity in high- versus low-risk communities and evaluate interventions to decrease risk of infection in these settings.

We wish Dr. Grunau great success with this exciting project!

Learn more:

This project is supported by funding from the Government of Canada, through the COVID-19 Immunity Task Force./ Ce projet a été soutenu par un financement du Gouvernement du Canada, par le biais du Secrétariat du groupe de travail sur l’immunité COVID-19.